Changes related to "Busulfan (Myleran)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 00:25, 23 June 2018
   
Page name:

22 June 2018

 m   19:57  Autologous HSCT‎‎ (2 changes | history) . . (+1,034). . [Jwarner‎; Warner-admin‎]
 m    19:57 (cur | prev) . . (+1,034). . Jwarner (talk | contribs) (R-BEAM {{#subobject:8b88db|Regimen=1}})
 m    19:49 (cur | prev) . . (0). . Warner-admin (talk | contribs) (Text replacement - "randozmied" to "randomized")

20 June 2018

 m   14:54  Autologous HSCT‎ (diff | hist) . . (+20). . Jwarner (talk | contribs) (References)
 m   11:33  CNS lymphoma‎ (diff | hist) . . (+49). . Jwarner (talk | contribs) (Upfront therapy, non-randomized or retrospective data)

19 June 2018

 m   17:49  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+11). . Jwarner (talk | contribs)
 m   17:05  CNS lymphoma‎ (diff | hist) . . (-171). . Jwarner (talk | contribs)
 m   16:39  Allogeneic HSCT‎ (diff | hist) . . (+58). . Jwarner (talk | contribs) (Reduced-intensity conditioning (RIC), all lines of therapy)
 m   16:32  Autologous HSCT‎ (diff | hist) . . (+89). . Jwarner (talk | contribs) (Low-dose conditioning regimens for cellular therapy, all lines of therapy)

18 June 2018

 m   20:41  Allogeneic HSCT‎ (diff | hist) . . (+1). . Jwarner (talk | contribs) (Myeloablative regimens, all lines of therapy)
 m   20:39  Autologous HSCT‎‎ (7 changes | history) . . (+1,114). . [Jwarner‎ (7×)]
 m    20:39 (cur | prev) . . (+2,126). . Jwarner (talk | contribs) (Bu/TT {{#subobject:e04a91|Regimen=1}})
 m    20:38 (cur | prev) . . (-2,106). . Jwarner (talk | contribs) (TBC {{#subobject:e04a91|Regimen=1}})
 m    17:57 (cur | prev) . . (+1,577). . Jwarner (talk | contribs) (Busulfan & Melphalan {{#subobject:484436|Regimen=1}})
 m    17:57 (cur | prev) . . (-1,577). . Jwarner (talk | contribs) (Busulfan & Cyclophosphamide {{#subobject:9acbe9|Regimen=1}})
 m    17:56 (cur | prev) . . (-90). . Jwarner (talk | contribs) (Bu/Cy {{#subobject:9acbe9|Regimen=1}})
 m    17:35 (cur | prev) . . (+75). . Jwarner (talk | contribs) (Bortezomib & Melphalan {{#subobject:9c28bc|Regimen=1}})
 m    17:34 (cur | prev) . . (+1,109). . Jwarner (talk | contribs) (Bor-HDM {{#subobject:9c28bc|Regimen=1}})
 m   17:27  Chronic lymphocytic leukemia (CLL/SLL)‎‎ (5 changes | history) . . (-3,648). . [Jwarner‎ (5×)]
 m    17:27 (cur | prev) . . (+147). . Jwarner (talk | contribs) (BendOfa {{#subobject:4eab04|Regimen=1}})
 m    17:24 (cur | prev) . . (+2,297). . Jwarner (talk | contribs) (CFAR {{#subobject:30ac6b|Regimen=1}})
 m    17:23 (cur | prev) . . (-2,273). . Jwarner (talk | contribs) (G-B {{#subobject:e26569|Regimen=1}})
 m    11:38 (cur | prev) . . (+21). . Jwarner (talk | contribs) (Placebo)
 m    11:27 (cur | prev) . . (-3,840). . Jwarner (talk | contribs) (Lenalidomide monotherapy {{#subobject:9820ba|Regimen=1}})
 m   16:55  Acute promyelocytic leukemia‎‎ (2 changes | history) . . (+221). . [Jwarner‎ (2×)]
 m    16:55 (cur | prev) . . (+2,145). . Jwarner (talk | contribs) (Arsenic trioxide, ATRA, Gemtuzumab ozogamicin {{#subobject:533ccc|Regimen=1}})
 m    16:49 (cur | prev) . . (-1,924). . Jwarner (talk | contribs) (Arsenic trioxide & ATRA {{#subobject:2b304d|Regimen=1}})

17 June 2018

 m   13:21  Acute promyelocytic leukemia‎ (diff | hist) . . (+784). . Jwarner (talk | contribs) (Arsenic trioxide monotherapy {{#subobject:734f95|Regimen=1}})